Bozena Bugaj-Gaweda

Bozena is a passionate scientist with multi-disciplinary expertise in molecular, cellular and cancer biology. She obtained her master’s degree from the City College of New York. Prior to joining Stelexis, Bozena was a part of the Antibody Drug Conjugate and Immunotherapeutic group at Pfizer Oncology R&D where she supported bispecific programs, which are currently in clinical trials. Bozena joined Stelexis in April 2020. Her hobbies are traveling and gardening.